San Francisco Sentry Investment Group’s Quest Diagnostics DGX Stock Holding History

San Francisco Sentry Investment Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$37K	Hold	282	–	–	0.02%	407
2021 Q1	$36K	Hold	282	–	–	0.02%	419
2020 Q4	$34K	Hold	282	–	–	0.02%	401
2020 Q3	$32K	Sell	282 -107	-28%	-$12.6K	0.02%	378
2020 Q2	$44K	Buy	389 +136	+54%	+$14.4K	0.02%	345
2020 Q1	$20K	Hold	253	–	–	0.01%	388
2019 Q4	$27K	Hold	253	–	–	0.01%	451
2019 Q3	$27K	Buy	253 +44	+21%	+$4.52K	0.01%	450
2019 Q2	$22K	Sell	209 -48	-19%	-$4.61K	0.01%	467
2019 Q1	$23K	Buy	257 +48	+23%	+$4.16K	0.01%	478
2018 Q4	$17K	Buy	209 +35	+20%	+$3.28K	0.01%	502
2018 Q3	$19K	Hold	174	–	–	0.01%	513
2018 Q2	$19K	Hold	174	–	–	0.01%	502
2018 Q1	$17K	Buy	174 +107	+160%	+$11K	﹤0.01%	612
2017 Q4	$7K	Buy	67 +36	+116%	+$3.41K	﹤0.01%	716
2017 Q3	$3K	Buy	+31	New	+$3.29K	﹤0.01%	801

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

San Francisco Sentry Investment Group's DGX Position: Q2 2021 in Review

San Francisco Sentry Investment Group held its Quest Diagnostics (DGX) position steady in Q2 2021 at 282 shares worth $37K. The position accounts for 0.02% of the portfolio, ranked #407.

San Francisco Sentry Investment Group first reported a position in DGX in Q3 2017 and has held it in 16 quarters since. The position peaked at $44K in Q2 2020. 815 funds tracked by Wall St. Rank hold DGX as of Q2 2021.

San Francisco Sentry Investment Group held 282 shares of Quest Diagnostics worth $37K as of Q2 2021.
San Francisco Sentry Investment Group left its Quest Diagnostics share count unchanged in Q2 2021.
Quest Diagnostics made up 0.02% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #407 holding.
San Francisco Sentry Investment Group first reported a position in Quest Diagnostics in Q3 2017 and has held it in 16 quarters since.
San Francisco Sentry Investment Group's Quest Diagnostics position peaked at $44K in Q2 2020.
815 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.